Preclinical and clinical development of targeted therapy in melanoma: attention to schedule
Author:
Publisher
Wiley
Subject
Dermatology,General Biochemistry, Genetics and Molecular Biology,Oncology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1755-148X.2009.00607.x/fullpdf
Reference3 articles.
1. Randomized phase II study of pulse erlotinib before or after carboplatin and paclitaxel in current or former smokers with advanced non-small-cell lung cancer;Riely;J. Clin. Oncol.,2009
2. Transient potent BCR-ABL inhibition is sufficient to commit chronic myeloid leukemia cells irreversibly to apoptosis;Shah;Cancer Cell,2008
3. Pulsatile administration of the epidermal growth factor receptor inhibitor Gefitinib is significantly more effective than continuous dosing for sensitizing tumors to paclitaxel;Solit;Clin. Cancer Res.,2005
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. In Vitro and In Vivo Studies of Melanoma Cell Migration by Antagonistic Mimetics of Adhesion Molecule L1CAM;International Journal of Molecular Sciences;2024-04-28
2. HO-1 Limits the Efficacy of Vemurafenib/PLX4032 in BRAFV600E Mutated Melanoma Cells Adapted to Physiological Normoxia or Hypoxia;Antioxidants;2022-06-14
3. Nuclear Localization of BRAFV600E Is Associated with HMOX-1 Upregulation and Aggressive Behavior of Melanoma Cells;Cancers;2022-01-09
4. Targeted Therapies: Friends or Foes for Patient’s NK Cell-Mediated Tumor Immune-Surveillance?;Cancers;2020-03-25
5. HO‐1 downregulation favors BRAF V600 melanoma cell death induced by Vemurafenib/PLX4032 and increases NK recognition;International Journal of Cancer;2019-08-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3